Shares of EOM Pharmaceutical Holdings, Inc. (OTCMKTS:IMUC – Get Free Report) traded up 90.5% during trading on Wednesday . The stock traded as high as $0.2479 and last traded at $0.2479. Approximately 110 shares changed hands during trading, a decline of 89% from the average session volume of 1,013 shares. The stock had previously closed at $0.1301.
EOM Pharmaceutical Price Performance
The firm’s 50 day simple moving average is $0.18 and its two-hundred day simple moving average is $0.16.
EOM Pharmaceutical Company Profile
EOM Pharmaceutical, trading under the ticker OTCMKTS:IMUC, is a clinical-stage biotechnology company focused on the development of cell-based immunotherapies for the treatment of solid tumors. The company leverages dendritic cell technology to create personalized therapeutic vaccines designed to activate a patient’s immune system against tumor-specific antigens. By harnessing key insights into antigen presentation and T-cell activation, EOM Pharmaceutical aims to improve survival outcomes for patients with cancers that currently have limited treatment options.
The company’s lead programs are directed at glioblastoma multiforme and other aggressive tumor types, where standard therapies often fall short.
Featured Articles
- Five stocks we like better than EOM Pharmaceutical
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for EOM Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
